Jennifer Griffin

US Patent:

20040077048, Apr 22, 2004

Filed:

Jul 31, 2003

Appl. No.:

10/467042

Inventors:

Bridget Warren - San Marcos CA, US
Cynthia Honchell - San Carlos CA, US
Yan Lu - Mountain View CA, US
Narinder Chawla - Union City CA, US
Neil Burford - Durham CT, US
Angelo Delegeane - Milpitas CA, US
Ameena Gandhi - San Francisco CA, US
Mariah Baughn - Los Angeles CA, US
Jennifer Griffin - Fremont CA, US
Kimberly Gietzen - San Jose CA, US
Dyung Aina Lu - San Jose CA, US
Craig Ison - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Y Tom Tang - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Mark Borowsky - Northampton CA, US
Brendan Duggan - Sunnyvale CA, US
April Hafalia - Daly City CA, US
Chandra Arvizu - San Diego CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Monique Yao - Mountain View CA, US
Vicki Elliott - San Jose CA, US
Li Ding - Creve Coeur MO, US
Henry Yue - Sunnyvale CA, US
Sally Lee - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Uyen Tan - San Jose CA, US
Yuming Xu - Mountain View CA, US

International Classification:

C12N009/64
C07H021/04
C07K016/40

US Classification:

435/069100, 435/226000, 435/320100, 435/325000, 530/388260, 536/023200

Abstract:

The invention provides human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.

US Patent:

20040092715, May 13, 2004

Filed:

Aug 6, 2003

Appl. No.:

10/467434

Inventors:

Li Ding - Creve Couer MO, US
Bridge Warren - San Marcos CA, US
Vicki Elliott - San Jose CA, US
Y Tang - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Neil Burford - Durham CT, US
Sally Lee - San Jose CA, US
Richardson Thomas - Redwood City CA, US
Preeti Lal - Santa Clara CA, US
Danniel Nguyen - San Jose CA, US
Junming Yang - San Jose CA, US
April Hafalia - Daly City CA, US
Craig Ison - San Jose CA, US
Rajagopal Gururajan - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Yumei Wang - Mountain View CA, US
Monique Yao - Mountain View CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Anita Swarnakar - San Francisco CA, US
Jennifer Griffin - Fremont CA, US
Ian Forsythe - Edmonton, CA
Brooke Emerling - Chicago IL, US
Narinder Chawla - Union City CA, US

International Classification:

C12Q001/68
C07H021/04
A61K038/17
C07K014/47

US Classification:

530/350000, 435/006000, 435/069100, 435/320100, 435/325000, 514/012000, 536/023500

Abstract:

The invention provides human intracellular signaling molecules (INTSIG) and polynucleotides which identify and encode INTSIG. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of INSTSIG.

US Patent:

20040115676, Jun 17, 2004

Filed:

Aug 6, 2003

Appl. No.:

10/467252

Inventors:

Mariah Baughn - Los Angeles CA, US
Catherine Tribouley - San Francisco CA, US
Danniel Nguyen - San Jose CA, US
Michael Thornton - Oakland CA, US
Monique Yao - Mountain View CA, US
Deborah Kallick - Galveston TX, US
Ameena Gandhi - San Francisco CA, US
Narinder Chawla - Union City CA, US
Chandra Arvizu - San Diego CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Pei Jin - Palo Alto CA, US
Y Tang - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Roopa Reddy - Sunnyvale CA, US
Neil Burford - Durham CT, US
Dyung Lu - San Jose CA, US
Richard Graul - San Francisco CA, US
Farrah Khan - Des Plaines IL, US
Roderick Walsh - Kent, GB
Craig Ison - San Jose CA, US
Thomas Richardson - Redwood City CA, US
Jennifer Griffin - Fremont CA, US
Bridget Warren - San Marcos CA, US
Junming Yang - San Jose CA, US
Ernestine Lee - Castro Valley CA, US
Lee Harland - Canterbury, GB

International Classification:

C12Q001/68
C07H021/04
C07K014/705
C07K016/28

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 530/388220, 536/023500

Abstract:

The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.

US Patent:

20040253598, Dec 16, 2004

Filed:

Mar 31, 2004

Appl. No.:

10/491471

Inventors:

Mariah Baughn - Los Angeles CA, US
Ernestine Lee - Kensington CA, US
Vicki Elliott - San Jose CA, US
Brendan Duggan - Sunnyvale CA, US
Joana Li - Millbrae CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Angelo Delegeane - Milpitas CA, US
Soo Lee - Mountain View CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Amy Kable - Silver Spring MD, US
Joseph Marquis - San Jose CA, US
Rajagopal Gururajan - San Jose CA, US
William Sprague - Sacramento CA, US
Junming Yang - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Yeganeh Zebarjadian - San Francisco CA, US
Thomas Richardson - Redwood City CA, US
Alan Jackson - Los Gatos CA, US
Xin Jiang - Saratoga CA, US
Shanya Becha - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C07K014/705

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

Various embodiments of the invention provide human vesicle-associated proteins (VAP) and polynucleotides which identify and encode VAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of VAP.

US Patent:

20040258679, Dec 23, 2004

Filed:

Mar 29, 2004

Appl. No.:

10/475476

Inventors:

Bridget Warren - San Marcos CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Henry Yue - Sunnyvale CA, US
Soo Lee - Mountain View CA, US
Y Tang - San Jose CA, US
Mariah Baughn - Los Angeles CA, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ann He - San Jose CA, US
Junming Yang - San Jose CA, US
Shanya Becha - San Francisco CA, US
Ian Forsythe - Edmonton, CA
Ann Gorvad - Bellingham WA, US
Jayalaxmi Ramkumar - Fremont CA, US
Brendan Duggan - Sunnyvale CA, US
Joana Li - Millbrae CA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Joseph Marquis - San Jose CA, US

International Classification:

A61K039/395
C07H021/04
C07K014/47
C07K016/18

US Classification:

424/130100, 435/069100, 435/320100, 435/325000, 530/350000, 530/388100, 536/023500

Abstract:

The invention provides human vesicle-associated proteins (VAP) and polynucleotides which identify and encode VAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of VAP.

US Patent:

20050069876, Mar 31, 2005

Filed:

Mar 29, 2002

Appl. No.:

10/473519

Inventors:

Mariah Baughn - Los Angeles CA, US
Neil Burford - Durham CT, US
Li Ding - Creve Coeur MI, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Ian Forsythe - Edmonton, CA
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - Fremont CA, US
Ann He - San Jose CA, US
Cynthia Honchell - San Carlos CA, US
Craig Ison - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Sally Lee - San Jose CA, US
Dyung Alina Lu - San Jose CA, US
Patricia Mason - Morgan Hill CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Anita Swarnakar - San Francisco CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Y Tom Tang - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Uyen Tran - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Monique Yao - Mountain View CA, US
Yuming Xu - Mountain View CA, US
Henry Yue - Sunnyvale CA, US

Assignee:

Incyte Corporation - Palo Alto CA

International Classification:

C12Q001/68
A01K067/00
C07H021/04
C12N009/00

US Classification:

435006000, 435069100, 435183000, 435320100, 435325000, 530350000, 536023200, 800008000

Abstract:

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

US Patent:

20050123912, Jun 9, 2005

Filed:

Aug 14, 2002

Appl. No.:

10/486977

Inventors:

Ines Barroso - Cambridge, GB
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Julie Blake - San Francisco CA, US
Mark Borowsky - Needham MA, US
Neil Burford - Durham CT, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton, CA
Kimberly Gietzen - San Jose CA, US
Ann Gorvad - Bellingham WA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Francisco CA, US
Craig Ison - San Jose CA, US
Farrah Khan - Canton MI, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Sally Lee - San Jose CA, US
Soo Lee - Mountain View CA, US
Joana Li - Millbrae CA, US
Dyung Lu - San Jose CA, US
Yan Lu - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
William Sprague - Sacramento CA, US
Y Tang - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Michael Thornton - Oakland CA, US
Uyen Tran - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Huibin Yue - Cupertino CA, US
Yeganeh Zebarjadian - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/22

US Classification:

435006000, 435069100, 435199000, 435320100, 435325000, 536023200

Abstract:

Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

US Patent:

20050142600, Jun 30, 2005

Filed:

Feb 1, 2005

Appl. No.:

11/046868

Inventors:

Bridget Warren - San Marcos CA, US
Cynthia Honchell - San Francisco CA, US
Yan Lu - Mountain View CA, US
Narinder Chawla - Union City CA, US
Neil Burford - Durham CT, US
Angelo Delegeane - Milpitas CA, US
Ameena Gandhi - San Francisco CA, US
Mariah Baughn - Los Angeles CA, US
Jennifer Griffin - Fremont CA, US
Kimberly Gietzen - San Jose CA, US
Dyung Lu - San Jose CA, US
Craig Ison - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Y. Tang - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Mark Borowsky - Needham MA, US
Brendan Duggan - Sunnyvale CA, US
April Hafalia - Daly City CA, US
Chandra Arvizu - San Diego CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Monique Yao - Mountain View CA, US
Vicki Elliott - San Jose CA, US
Li Ding - Creve Coeur MO, US
Henry Yue - Sunnyvale CA, US
Sally Lee - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Uyen Tran - San Jose CA, US
Yuming Xu - Mountain View CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/64

US Classification:

435006000, 435069100, 435226000, 435320100, 435325000, 530388260, 536023200

Abstract:

The invention provides human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.